Role of RNF213 polymorphism in defining quasi-moyamoya disease and definitive moyamoya disease

Neurosurg Focus. 2021 Sep;51(3):E2. doi: 10.3171/2021.5.FOCUS21182.

Abstract

Objective: Quasi-moyamoya disease (QMMD) is moyamoya disease (MMD) associated with additional underlying diseases. Although the ring finger protein 213 (RNF213) c.14576G>A mutation is highly correlated with MMD in the Asian population, its relationship to QMMD is unclear. Therefore, in this study the authors sought to investigate the RNF213 c.14576G>A mutation in the genetic diagnosis and classification of QMMD.

Methods: This case-control study was conducted among four core hospitals. A screening system for the RNF213 c.14576G>A mutation based on high-resolution melting curve analysis was designed. The prevalence of RNF213 c.14576G>A was investigated in 76 patients with MMD and 10 patients with QMMD.

Results: There were no significant differences in age, sex, family history, and mode of onset between the two groups. Underlying diseases presenting in patients with QMMD were hyperthyroidism (n = 6), neurofibromatosis type 1 (n = 2), Sjögren's syndrome (n = 1), and meningitis (n =1). The RNF213 c.14576G>A mutation was found in 64 patients (84.2%) with MMD and 8 patients (80%) with QMMD; no significant difference in mutation frequency was observed between cohorts.

Conclusions: There are two forms of QMMD, one in which the vascular abnormality is associated with an underlying disease, and the other in which MMD is coincidentally complicated by an unrelated underlying disease. It has been suggested that the presence or absence of the RNF213 c.14576G>A mutation may be useful in distinguishing between these disease types.

Keywords: RNF213 c.14576G>A mutation; quasi-moyamoya disease; vascular disorders.

MeSH terms

  • Adenosine Triphosphatases / genetics
  • Case-Control Studies
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Moyamoya Disease* / epidemiology
  • Moyamoya Disease* / genetics
  • Ubiquitin-Protein Ligases / genetics

Substances

  • RNF213 protein, human
  • Ubiquitin-Protein Ligases
  • Adenosine Triphosphatases